Explanation
Concomitantfolinicacidand5FUareusually prescribed
Oxatolatinisucensedforthetreatmentof metastaticcolorectaucarcinomaincombination withfuorouracu and
folinicacidandtisthereforenot routinety administered as amonotherapv.tis qiven by intravenous infusion.
Thedose
uimitedbyneurotoxicityusuallysensorypolyneuropathy)andtdoesnotusualy causeamotor
neuropathy.Otherside-effects includeGl toxicity. ototoxicity and myeosuppression.Renatfunctiommonitoring
isadvisedincasesofmoderaterenauimoairment.
NlCEquidance(fromMarch 2002)recommendsthatoxaliolatinusebeconfinedtothose patientswhohave
Uiver metastasesonuvandwhichmiahtbeamenabletosuraicauresection afterchemotheraov.lrinotecan
theraov mav beconsideredin patients who havefailedorespondtoaplatinum-containinqtherapv.
@1MIN ENDOCRINE
